Navigation Links
Results Published In Journal of Cystic Fibrosis Confirm CREON(R) (pancrelipase) Delayed-Release Capsules Improves Fat Absorption in Patients With Cystic Fibrosis
Date:10/9/2009

, including CREON®. Caution should be exercised when administering pancrelipase to a patient with a known allergy to proteins of porcine origin.

In the clinical study used to demonstrate the efficacy and safety of FDA-approved CREON®, the incidence of adverse events (regardless of causality) was higher during placebo treatment (71%) than during CREON® treatment (50%). Treatment-emergent adverse events occurring in at least two patients (greater than or equal to 6%) receiving CREON® or placebo were abdominal pain, abdominal pain upper, abnormal feces, cough, dizziness, flatulence, headache, and weight decreased.

CREON® has been approved with a Risk Evaluation and Mitigation Strategy (REMS) to ensure that the benefits of the drug outweigh its risks. As part of the REMS, a Medication Guide with important dosing and safety information applicable to this class of products, including CREON®, is provided for patients and caregivers, with an emphasis on understanding the risk of fibrosing colonopathy as well as the importance of not over- or under-dosing. The FDA requires that the Medication Guide be handed out with every prescription for the drug dispensed.

For full safety and Prescribing Information about the FDA-approved formulation of CREON®, visit www.CREON.com.

Solvay Pharmaceuticals, Inc., of Marietta, Georgia, is the U.S. subsidiary of Solvay Pharmaceuticals. For more information, visit www.solvaypharmaceuticals-us.com.

Solvay Pharmaceuticals is a research driven group of companies that constitutes the global pharmaceutical business of the Solvay Group. These companies seek to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardiometabolic, influenza vaccines, gastroenterology and men's and women's health. Its 2008 sales were EUR 2.7 billion and it
'/>"/>

SOURCE Solvay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009
2. CareFusion Will Host An Earnings Conference Call on November 10, 2009 to Discuss the Results for the First Quarter of Fiscal 2010
3. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2010
4. NuVasive Announces Conference Call and Webcast of Third Quarter 2009 Results
5. Medco Announces Date for Third-Quarter 2009 Financial Results; Company to Provide 2010 Earnings Guidance
6. TOPICA Announces Positive Phase 2 Clinical Results for Luliconazole, a Potent Topical Antifungal
7. Robbins & Myers Announces Fourth Quarter and Full Year 2009 Results
8. Cantel Medical Corp. To Hold Conference Call To Discuss Fourth Quarter and Fiscal 2009 Results
9. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2009 Results
10. ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2009 Financial Results
11. Immucor Announces Fiscal First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... -- The Make-A-Wish Foundation announced today that it ... LATISSE ® Wishes ... ,, Based on the tradition of blowing on ... the campaign launched earlier this year to raise ... leveraging the excitement around the availability of LATISSE® ...
(Date:12/16/2009)... Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: ... 2010 the U.S. Food and Drug Administration,s ... the New Drug Application (NDA) for pixantrone ... lymphoma (NHL). ODAC is an independent panel ... efficacy and safety of marketed and investigational ...
(Date:12/16/2009)... 16 MedSolutions ( www.medsolutions.com ), a ... commended two new studies highlighting the dangers of ... diagnostic imaging tests. ,, "When used properly, ... treatment," said Gregg Allen, M.D., chief medical officer ... compelling evidence that stricter quality control measures are ...
Breaking Medicine Technology:The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign 2The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign 3The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign 4The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign 5Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 2Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 3Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 4MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 3Cardio Vascular Medical Device to Apply for Additional Patents in Europe Canada and Far East 61861 1Cardio Vascular Medical Device to Apply for Additional Patents in Europe Canada and Far East 61861 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 6445 1Unilens Vision Reports Record First Quarter Earnings and Royalty Income 6445 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 6445 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 6445 4High blood pressure easy to miss in children with kidney disease 61855 1High blood pressure easy to miss in children with kidney disease 61855 2
... 21, 2007 - Neurologix, Inc.,(OTCBB:NRGX) today announced the ... The Lancet of positive results from the first ... first report of,direct gene transfer into a patient's ... open label Phase 1 study, conducted in 12 ...
... 21, 2007 - The,PromegaExpress(TM) on-site stocking program just ... of on-site appliances. This,latest addition serves as great ... areas when space is at a premium,but immediate ... The,mid-sized cabinet can also be stacked with another ...
Other Medicine Technology:Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 3Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 4Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 5Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 6
(Date:12/17/2009)... Stevens Hospital Expand, Improve Quality of Care and ... The Board of Commissioners for Public ... non-binding terms for Swedish to lease and assume ... summer, pending regulatory approvals and final agreements. The ... to learn more about the affiliation. A final ...
(Date:12/17/2009)... comes from physician, study finds , , THURSDAY, Dec. 17 ... influence in convincing parents to place infants on their ... sudden infant death syndrome, or SIDS, researchers have found. ... Sleep" campaign in 1994, the number of infants placed ... 25 percent to 70 percent, and the rate of ...
(Date:12/17/2009)... counters of clothing stores, gas stations -- and adding to ... -- If you,re hungry while shopping for a new sofa, ... sweet or salty snacks, a new report finds. , In ... beyond grocery stores to hit most segments of the retail ... 17 in the American Journal of Public Health . ...
(Date:12/17/2009)... takes the stage at the Fisher Theatre on Dec. 17 for ... and cancer survivors will be the real stars of the show. ... ... the cast takes the stage at the Fisher Theatre on Dec. ... Beaumont cancer patients and cancer survivors will be the ...
(Date:12/17/2009)... more likely to try alcohol, illegal drugs , , THURSDAY, ... smoking cigarettes is riskier than using illicit drugs or ... perception may increase the likelihood that they,ll experiment with ... "We are on the right track with cigarette smoking ... the dangers of other substances," Pamela S. Hyde, administrator ...
Breaking Medicine News(10 mins):Health News:Stevens Hospital to Affiliate with Swedish 2Health News:Stevens Hospital to Affiliate with Swedish 3Health News:Stevens Hospital to Affiliate with Swedish 4Health News:Doctor's Orders Influence Baby's Sleep Position 2Health News:Wide Array of Stores Now Sell High-Calorie Snacks 2Health News:Jersey Boys' Premiere Benefits Cancer Patients While Launching Beaumont Hospitals Fundraising Campaign 2Health News:Jersey Boys' Premiere Benefits Cancer Patients While Launching Beaumont Hospitals Fundraising Campaign 3Health News:Teens Think Smoking More Dangerous Than Drinking, Drugs 2
... ARLINGTON, Va., Nov. 5 The Generic,Pharmaceutical Association (GPhA) ... Kathleen Jaeger on the 2008 election results:, All ... with,economic issues top of mind. Our new President and ... economy, including rising health,care costs. One way to significantly ...
... solutions in ... healthcare environments, ANDOVER, Mass., ... are the most widely implemented in,healthcare, will be featured in ... next week in Orlando, Florida.,Sentillion will also be exhibiting at ...
... are two of the key factors that health professionals need ... active teenagers. , Researchers from the University of Sheffield, UK, ... aged 14 to 16 viewed a series of sexual scenarios. ... groups were more likely to see their partner,s point of ...
... would like to,applaud both presidential candidates and congratulate ... States, on his historic campaign and,election win. This ... senators, and the toughest of challenges are yet ... insurer, WellPoint appreciates that,health care will be a ...
... allows S2383 to be used as a flavor ingredient in commercial ... products in the U.S. ... Inc.,(Nasdaq: SNMX ), a leading company focused on using proprietary ... and,ingredient supply industries, announced today that it has been notified by,the ...
... Companies, the nation,s,leading healthcare-exclusive call center, was selected by ... places to work in healthcare." The new,program recognizes innovative ... this recognition to past "best places to work" awards,including:, ... from the Society for Human Resource,Management., -- Best ...
Other Medicine News:Health News:GPhA Congratulates President-Elect Barack Obama and New Congress and Urges Action on Increasing Access to Generic -- and Biogeneric -- Medicines 2Health News:Sentillion and Baptist Health System to Speak at Upcoming Gartner Identity & Access Management Summit 2Health News:Alcohol advice needs to play a greater role in sex education for teenagers 2Health News:Alcohol advice needs to play a greater role in sex education for teenagers 3Health News:WellPoint Congratulates President-Elect Barack Obama 2Health News:SENOMYX RECEIVES GENERALLY RECOGNIZED AS SAFE (GRAS) DETERMINATION FOR S2383 SUCRALOSE ENHANCER 2Health News:SENOMYX RECEIVES GENERALLY RECOGNIZED AS SAFE (GRAS) DETERMINATION FOR S2383 SUCRALOSE ENHANCER 3Health News:SENOMYX RECEIVES GENERALLY RECOGNIZED AS SAFE (GRAS) DETERMINATION FOR S2383 SUCRALOSE ENHANCER 4Health News:Modern Healthcare Names The Beryl Companies One of Best Places to Work in Healthcare 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: